Author

Rhett P. Katterling

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5062959142

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS

2014 · Amer M. Zeidan, Ju‐Whei Lee, et al. · British Journal of Haematology · 29

Works count: 1

Citation count: 29

H-index: 1

I10-index: 1